HEIDI HUDEK: Open Payments
NPI 1801102074 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 22 payments from 8 companies in 2025. Trend: 2023 $1,218 · 2024 $1,104 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $703 |
| Lilly USA, LLC | 2 | $144 |
| Amgen Inc. | 3 | $61 |
| Kestra Medical Technology Services, Inc. | 2 | $47 |
| HEARTFLOW, INC. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
Products named: Wegovy, Ozempic, ZEPBOUND, Assure WCD, FFRct, LEQVIO, EVKEEZA, REPATHA.
Industry payments across PA — which companies pay providers there.
